Adalat and Simulect drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adalat (nifedipine) and Simulect (basiliximab). Common drug interactions include white blood cell disorder among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Adalat and Simulect. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Simulect?

Simulect has active ingredients of basiliximab. eHealthMe is studying from 3,861 Simulect users. Check the latest studies of Simulect.

On Aug, 08, 2026

67 people who take Adalat and Simulect together, and have interactions are studied.

What are the common drug interactions of Adalat and Simulect, by gender? *:

female:

White blood cell disorder
Wound infection staphylococcal
Wound secretion
Bacterial test positive
Hip arthroplasty
Haemoglobin decreased
Renal impairment (severely reduced kidney function)
Urine output decreased
Capillary leak syndrome (capillary leaks plasma)
Cytomegalovirus infection

male:

Pyrexia (fever)
Blood creatinine increased
Impaired healing
Wound decomposition
Proteinuria (presence of protein in the urine)
Malaise (a feeling of general discomfort or uneasiness)
Oedema peripheral (superficial swelling)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Cytomegalovirus test positive
Herpes zoster

What are the common drug interactions of Adalat and Simulect, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Capillary leak syndrome (capillary leaks plasma)
Pyrexia (fever)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Ascites (accumulation of fluid in the abdominal cavity)
Blood pressure fluctuation
Cardiac arrest
Cardiovascular disorder (heart diseases)
General physical health deterioration (weak health status)
Haemodynamic instability (disturbances in the blood movement in our body)
Pericardial effusion (fluid around the heart)

10-19:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Coagulopathy (blood's ability to clot is impaired)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Multi-organ failure (multisystem organ failure)
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Bone marrow failure
Lung infection
Agitation postoperative

20-29:

n/a

30-39:

Blood creatinine increased
Renal disorder (kidney disease)
Abscess (pus)
Chronic allograft nephropathy (failure of kidney transplant)
Effusion (an escape of fluid into a body cavity)
Fluid retention (an abnormal accumulation of fluid in the blood)
Impaired healing
Nephropathy (damage to or disease of a kidney)
Pyrexia (fever)
Wound decomposition

40-49:

Pneumonia bacterial (pneumonia associated with bacterial infection)
Small intestinal haemorrhage (bleeding from small intestine)
Transplant rejection (a transplant material is not worked)
Pyrexia (fever)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Cytomegalovirus infection
Blood creatinine increased
C-reactive protein increased
Decreased appetite
Duodenitis (inflammation of the duodenum)

50-59:

Gait disturbance
Osteonecrosis (death of bone)
White blood cell disorder
Wound infection staphylococcal
Wound secretion
Bacterial test positive
Hip arthroplasty
Kidney transplant rejection
Haemoglobin decreased
Cytomegalovirus infection

60+:

Malaise (a feeling of general discomfort or uneasiness)
Oedema peripheral (superficial swelling)
Proteinuria (presence of protein in the urine)
Influenza
Renal disorder (kidney disease)
Anuria (failure of the kidneys to produce urine)
Hydronephrosis (water inside the kidney)
Kidney transplant rejection

What are the existing conditions these people have? *

High Blood Cholesterol: 10 people, 14.93%
Lung Infection: 6 people, 8.96%
Renovascular Hypertension (a syndrome which consists of high blood pressure caused by the kidneys hormonal response): 5 people, 7.46%
Osteoporosis (bones weak and more likely to break): 5 people, 7.46%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 5 people, 7.46%
Enlarged Prostate: 5 people, 7.46%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 5 people, 7.46%
Constipation: 5 people, 7.46%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 5 people, 7.46%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and Simulect?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously